Jupiter: Clinical Trials

5 trials of Jupiter, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting. 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 42Active not recruiting 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Jupiter: new trials by email Literature Review of Jupiter trials Research Report on Jupiter

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IO Vancomycin in TSA
Intervention - Intraosseous (IO) administration of vancomycin, Control - Standard IV administration of vancomycin - Shoulder Injuries
Phase 4Active not recruitingThe Methodist Hospital Research Institute332023-06-012025-09-22
Safety and Efficacy Study of IMSA101 in Refractory Malignancies
IMSA101, Immune checkpoint inhibitor (ICI), Immuno-oncology (IO) therapy - Solid Tumor, Adult
Phase 1 / Phase 2CompletedImmuneSensor Therapeutics Inc.402019-09-232024-12-11
Intraosseous Catheter Confirmation Study
Standard intraosseous (IO) catheter confirmation procedure, Color flow Doppler intraosseous (IO) catheter confirmation procedure, Pressure transduction intraosseous (IO) catheter confirmation procedure - Critical Illness
Not applicableCompletedRutgers, The State University of New Jersey342019-07-232023-09-08
Nasal Naloxone for Narcotic Overdose
Intranasal (IN) naloxone, Intravenous (IV) naloxone, Intramuscular (IM) naloxone - Drug Overdose
Phase 4UnknownJudith Feinberg2362013-09-012013-07-31
Stem Cell Ophthalmology Treatment Study
RB (Retrobulbar), ST (Subtenon), IV (Intravenous) - Retinal Disease, Macular Degeneration
Not applicableUnknownMD Stem Cells3002012-08-012019-10-23

Conditions studied

Cone Dystrophy (1)  ·  Cone-Rod Dystrophies (1)  ·  Critical Illness (1)  ·  Drug Overdose (1)  ·  Eye Diseases (1)  ·  Geographic Atrophy (1)  ·  Glaucoma (1)  ·  Macular Degeneration (1)  ·  Neuromyelitis Optica (1)  ·  Optic Atrophy (1)  ·  Optic Nerve Diseases (1)  ·  Optic Nerve Injuries (1)  ·  Optic Neuropathy, Ischemic (1)  ·  Retinal Diseases (1)  ·  Retinal Dystrophies (1)

Sponsors

ImmuneSensor Therapeutics Inc. (1)  ·  Judith Feinberg (1)  ·  MD Stem Cells (1)  ·  Rutgers, The State University of New Jersey (1)  ·  The Methodist Hospital Research Institute (1)

Countries

United States (5)

Top investigators

Jeffrey Weiss, MD (1)  ·  Judith Feinberg, MD (1)  ·  Steven Levy, MD (1)  ·  Teresa S Mooneyham (1)  ·  Yonatan Greenstein, MD (1)

Results publications

PMID 26199618, PMID 26604914, PMID 27857759, PMID 27904503, PMID 32568958, PMID 37647305, PMID 40533265